Company profile for Cerus Corporation

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Cerus Corporation is dedicated solely to safeguarding the world’s blood supply and aims to become the preeminent global blood products company, deploying and supplying vital technologies and pathogen-protected blood components for blood centers, hospitals and ultimately patients who rely on safe blood. With the INTERCEPT Blood System, we are focused on protecting patients by delivering the full complement of reliable product...
Cerus Corporation is dedicated solely to safeguarding the world’s blood supply and aims to become the preeminent global blood products company, deploying and supplying vital technologies and pathogen-protected blood components for blood centers, hospitals and ultimately patients who rely on safe blood. With the INTERCEPT Blood System, we are focused on protecting patients by delivering the full complement of reliable products and expertise for transfusion medicine. Cerus develops and markets the INTERCEPT Blood System, and remains the only company in the blood transfusion space to earn both CE Mark and FDA approval.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
1220 Concord Avenue Concord, CA US 94520
Telephone
Telephone
+1 925.288.6000
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20251021249458/en/Cerus-Corporation-Announces-Abstracts-and-Industry-Workshop-on-IFC-at-the-2025-AABB-Annual-Meeting

BUSINESSWIRE
21 Oct 2025

https://www.businesswire.com/news/home/20250825692652/en/The-German-National-Blood-Advisory-Committee-Issues-Formal-Recommendation-for-Improving-the-Safety-of-Platelet-Transfusions

BUSINESSWIRE
25 Aug 2025

https://www.businesswire.com/news/home/20250721154296/en/Cerus-Corporation-Announces-Additional-Department-of-Defense-Award-to-Advance-Care-for-Major-Hemorrhage-in-Traumatic-Injury

BUSINESSWIRE
21 Jul 2025

https://www.businesswire.com/news/home/20250702232469/en/Cerus-Corporation-Provides-INTERCEPT-Red-Blood-Cell-CE-Mark-Application-Update

BUSINESSWIRE
02 Jul 2025

https://www.businesswire.com/news/home/20250613811092/en/Cerus-Corporation-Celebrates-World-Blood-Donor-Day-2025

BUSINESSWIRE
13 Jun 2025

https://www.businesswire.com/news/home/20241016501738/en

BUSINESSWIRE
16 Oct 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty